Byondis
Nijmegen, Netherlands byondis.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Byondis is a biopharmaceutical company focused on developing proprietary cancer medicines, especially antibody-drug conjugates and other targeted modalities. It conducts in-house research, development, and GMP manufacturing for its own pipeline and works from Nijmegen, The Netherlands.
Services
Research and development
In-house drug discovery and development for targeted medicines based on new biological and chemical entities, with biomarker and combination strategy work.
ADC platform development
Development of antibody-drug conjugate platforms including antifolate ADCs, masked therapeutics, phosphonate ADCs, and duocarmazine-based technologies.
Protein engineering and conjugation technologies
Protein modification services including site-specific conjugation, antibody conjugation, and dual-linker or branched-linker technologies.
Cell line development and cell culture
Cell line development and cell culture capabilities supporting biologics research and manufacturing.
Protein purification and formulation
Protein purification, analytics, and formulation work for biologics and conjugates.
GMP manufacturing
In-house GMP manufacturing and conjugation facilities for mAbs and ADCs up to early commercial launch scale.
ADC material and IMP release
Manufacturing and release of ADC material and investigational medicinal product for clinical programs.
Antifolate ADC platform
Develops an antifolate linker-drug platform intended to overcome ADC resistance and systemic side effects in oncology programs.
6 more services
- Masked therapeutics platform
- Phosphonate ADC platform
- Integrated R&D
- Manufacturing
- Protein purification and modification
- Small-molecule chemistry
Capabilities
- Assays and studies
- ADCs
- Antibodies
- Process development
- Small molecules
- In vitro efficacy
- In vivo efficacy
3 more
- PK/PD studies
- Safety studies
- Biomarker identification
- Scale and capacity
- Dual 2,000L bioreactors
- 73,000 square meters
- 2,000 m2 of laboratory space
- 2,400 m2 office space
- 800 m2 GMP warehouse
- About 200 employees
- Therapeutic areas
- Oncology
- Immunology
Instruments and platforms
- Single-use bioreactors
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Species and models
- Various tumor models
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: GMP (Manufacturing and conjugation facilities)
Industries served
- Oncology
Details
- Type
- CRDMO
- Founded
- 2007
- Team
- About 200 highly qualified employees
- Address
- Microweg 22 6545 CM Nijmegen, The Netherlands VAT number: NL8511.30.975
- Phone
- +31 (0)24 679 5100